Researchers from the School of Biomedical Engineering & Imaging Sciences and the Glioma MR Imaging 2.0 (GliMR) initiative, have released a two-part position statement summarizing evidence for use of advanced MRI techniques as brain cancer monitoring biomarkers in the clinic, highlighting the latest bench-to-bedside developments. They also discuss emerging topics and indicate the evidence gaps, strengths and limitations. The statement is a result of a joint effort of researchers from eight European countries and the US.
Researchers put forward evidence for use of advanced MRI techniques as brain cancer monitoring biomarkers
Researchers from the School of Biomedical Engineering & Imaging Sciences and the Glioma MR Imaging 2.0 (GliMR) initiative, have released a two-part position statement summarizing evidence for use of advanced MRI techniques as brain cancer monitoring biomarkers in the clinic, highlighting the latest bench-to-bedside developments. They also discuss emerging topics and indicate the evidence gaps, strengths and limitations. The statement is a result of a joint effort of researchers from eight European countries and the US.